Tolvaptan (JYNARQUE) 45MG/15MG NDC: 59148-0087-28
Ended Awarded
- Contract number
- 36C26124N0772
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a delivery order award from the Veterans Integrated Service Network 21 on July 15, 2024, for the supply of Tolvaptan (Jynarque) 45mg/15mg tablets with a ceiling value of $12,580.72. This firm fixed-price delivery order, which has an ultimate completion date of August 15, 2024, is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Potomac, Maryland, where Otsuka America manufactures the medication for distribution to VA facilities.
This delivery order represents one component of Otsuka America's substantial relationship with the Department of Veterans Affairs, specifically supporting the Veterans Health Administration's mission to provide specialized pharmaceutical treatments to eligible veterans. The award derives from a broader Blanket Purchase Agreement valued at $83.3 million for Jynarque, which was established under the National Acquisition Center and enables multiple VA Integrated Service Networks to efficiently procure this medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. Jynarque delivery orders are routinely distributed across multiple VISNs, demonstrating the medication's critical role in the VA's comprehensive healthcare services.
Quick answers
Who was awarded contract 36C26124N0772?
36C26124N0772 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 15, 2024.
How much is contract 36C26124N0772 worth?
The government has obligated $12,581 on 36C26124N0772.
Is contract 36C26124N0772 an order under another contract?
Yes. 36C26124N0772 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0772 competed?
The extent of competition for 36C26124N0772 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award